or Try an Advanced Search...

    Technical Analysis for IMRN - Immuron Limited

    Grade Last Price % Change Price Change
    D 2.50 -0.29% -0.01
    IMRN closed down 0.29 percent on Wednesday, May 8, 2024, on 0 percent of normal volume.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Up
    Historical IMRN trend table...
    Date Alert Name Type % Chg
    MACD Bullish Signal Line Cross Bullish 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Gapped Down Weakness 0.00%
    20 DMA Resistance Bearish -0.29%
    50 DMA Resistance Bearish -0.29%
    Gapped Up Strength -0.29%
    20 DMA Resistance Bearish -0.88%
    50 DMA Resistance Bearish -0.88%
    Narrow Range Bar Range Contraction -0.88%
    Fell Below 50 DMA Bearish -0.69%
    Older End-of-Day Signals for IMRN ...

       Recent Intraday Alerts

    Alert Time
    10 DMA Support about 10 hours ago
    Fell Below Previous Day's Low about 13 hours ago
    Down 1% about 13 hours ago
    Fell Below 10 DMA about 13 hours ago
    60 Minute Opening Range Breakdown 1 day ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    IMRN Chart by TradingView
    Basic chart:

    Profile

    Immuron Limited Description

    Immuron Limited, a microbiome company, focuses on developing and commercializing oral immunotherapeutics for the treatment of various gut medicated diseases in Australia and internationally. The company operates through Research and Development, and HyperImmune Products segments. It has a technology platform that enables a shorter development therapeutic cycle. The company markets and sells Travelan for the prevention of travellers’ diarrhea. Its lead product candidate IMM-124E is in Phase 2b clinical trials for NASH and ASH. The company also has other preclinical immunotherapy pipeline products targeting immune-related diseases. Immuron Limited has a research and development collaboration agreement with the Walter Reed Army Institute of Research (WRAIR) for the development of a Shigella vaccine; and Naval Medical Research Center for the testing of Travelan in cell lines of campylobacter and enterotoxigenic escherichia coli. The company was founded in 1994 and is based in Blackburn North, Australia.

    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Disease Immunotherapy Medical Research Microbiology Diarrhea Bacteria Immunotherapeutics Gram Negative Bacteria Tropical Diseases Immune Related Diseases Shigella

    Is IMRN a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 15 Immuron to host Live Virtual Event
    Apr 10 Immuron gains after Travelan sales update
    Apr 10 Immuron Travelan® sales continued strong growth
    Mar 11 Why Fangdd Network Group Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket
    Mar 8 We're Not Very Worried About Immuron's (ASX:IMC) Cash Burn Rate
    Mar 7 Immuron surges after mid-stage data for antidiarrheal med
    Mar 7 Immuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the US
    Feb 13 Immuron up 3% on record Travelan sales
    Feb 13 Immuron achieves record Travelan® sales
    Jan 16 Immuron achieves record half yearly Travelan® sales
    See more IMRN news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 5.96
    52 Week Low 1.481
    Average Volume 1,133,508
    200-Day Moving Average 2.06
    50-Day Moving Average 2.59
    20-Day Moving Average 2.51
    10-Day Moving Average 2.49
    Average True Range 0.17
    RSI (14) 49.24
    ADX 14.36
    +DI 25.56
    -DI 27.13
    Chandelier Exit (Long, 3 ATRs) 2.57
    Chandelier Exit (Short, 3 ATRs) 2.67
    Upper Bollinger Bands 2.76
    Lower Bollinger Band 2.25
    Percent B (%b) 0.5
    BandWidth 20.47
    MACD Line -0.02
    MACD Signal Line -0.02
    MACD Histogram 0.0008
    Fundamentals Value
    Market Cap 14.25 Million
    Num Shares 5.69 Million
    EPS -0.43
    Price-to-Earnings (P/E) Ratio -5.82
    Price-to-Sales 6.33
    Price-to-Book 0.80
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.57
    Resistance 3 (R3) 2.56 2.53 2.56
    Resistance 2 (R2) 2.53 2.51 2.53 2.55
    Resistance 1 (R1) 2.52 2.50 2.52 2.52 2.55
    Pivot Point 2.49 2.49 2.49 2.49 2.49
    Support 1 (S1) 2.47 2.47 2.48 2.48 2.46
    Support 2 (S2) 2.45 2.46 2.45 2.45
    Support 3 (S3) 2.43 2.45 2.45
    Support 4 (S4) 2.44